The World Council of Churches – Ecumenical Advocacy Alliance (WCC-EAA) welcomes the 25 April announcement by the Medicines Patent Pool (MPP) and ViiV Healthcare of the geographic extension of their licensing agreement for dolutegravir (DTG) to cover all remaining lower middle-income countries (LMICs). The amendment to the 2014 licence specifically allows generic medicine distribution in four countries with patents – Armenia, Moldova, Morocco and Ukraine – that were not covered in the initial agreement. Dolutegravir is a promising new treatment that was included in the latest WHO guidelines as first- and third-line treatment.
28 April 2016